CY1121976T1 - Μεθοδος για την παραγωγη παραγωγων υδροξυαιθυλαμυλου - Google Patents

Μεθοδος για την παραγωγη παραγωγων υδροξυαιθυλαμυλου

Info

Publication number
CY1121976T1
CY1121976T1 CY20191100704T CY191100704T CY1121976T1 CY 1121976 T1 CY1121976 T1 CY 1121976T1 CY 20191100704 T CY20191100704 T CY 20191100704T CY 191100704 T CY191100704 T CY 191100704T CY 1121976 T1 CY1121976 T1 CY 1121976T1
Authority
CY
Cyprus
Prior art keywords
temperature
value
production
solution
hydroxyethyl starch
Prior art date
Application number
CY20191100704T
Other languages
English (en)
Inventor
Werner Zimmermann
Jan Lukowczyk
Original Assignee
Serumwerk Bernburg Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44799422&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1121976(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Serumwerk Bernburg Ag filed Critical Serumwerk Bernburg Ag
Publication of CY1121976T1 publication Critical patent/CY1121976T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00Preparation of derivatives of starch
    • C08B31/08Ethers
    • C08B31/12Ethers having alkyl or cycloalkyl radicals substituted by heteroatoms, e.g. hydroxyalkyl or carboxyalkyl starch
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/26Iron; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00Preparation of derivatives of starch
    • C08B31/08Ethers
    • C08B31/10Alkyl or cycloalkyl ethers
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00Preparation of derivatives of starch
    • C08B31/18Oxidised starch
    • C08B31/185Derivatives of oxidised starch, e.g. crosslinked oxidised starch

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Η εφεύρεση αναφέρεται σε μια μέθοδο για την παραγωγή ενός τροποποιημένου υδροξυαιθυλαμύλου που φέρει ένα κατάλοιπο επτονικού οξέος σε τουλάχιστον ένα από τα άκρα του. Σύμφωνα με την εφεύρεση, εκτελούνται τα ακόλουθα στάδια: a) διάλυσης υδροξυαιθυλαμύλου σε ύδωρ, b) ρύθμισης της τιμής του pΗ σε μια τιμή από 8,0 έως 10,0, c) προσθήκης μιας ένωσης κυανιδίου στο διάλυμα υδροξυαιθυλαμύλου, θέρμανσης του διαλύματος σε μια θερμοκρασία από 80 έως 99°C και διατήρησης του σε αυτή τη θερμοκρασία για μια πρώτη χρονική περίοδο, και d) ρύθμισης της τιμής του pΗ σε μια τιμή από 2,0 έως 4,0, μεταφοράς του διαλύματος σε μια θερμοκρασία από 50 έως 90°C και διατήρησης του σε αυτή τη θερμοκρασία για μια δεύτερη χρονική περίοδο.
CY20191100704T 2011-06-21 2019-07-03 Μεθοδος για την παραγωγη παραγωγων υδροξυαιθυλαμυλου CY1121976T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11170761A EP2537866A1 (en) 2011-06-21 2011-06-21 Hydroxyethyl starch derivatives, method for manufacturing the same and therapeutical uses thereof
EP12737229.0A EP2723774B1 (en) 2011-06-21 2012-06-21 Method for manufacturing hydroxyethyl starch derivatives
PCT/EP2012/061958 WO2012175608A1 (en) 2011-06-21 2012-06-21 Method for manufacturing hydroxyethyl starch derivatives

Publications (1)

Publication Number Publication Date
CY1121976T1 true CY1121976T1 (el) 2020-10-14

Family

ID=44799422

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20191100704T CY1121976T1 (el) 2011-06-21 2019-07-03 Μεθοδος για την παραγωγη παραγωγων υδροξυαιθυλαμυλου

Country Status (21)

Country Link
US (2) US9181353B2 (el)
EP (2) EP2537866A1 (el)
JP (2) JP6370217B2 (el)
CN (2) CN103649128B (el)
BR (1) BR112013032901A2 (el)
CA (1) CA2837784C (el)
CY (1) CY1121976T1 (el)
DK (1) DK2723774T3 (el)
ES (1) ES2733767T3 (el)
HK (1) HK1220218A1 (el)
HR (1) HRP20191173T1 (el)
HU (1) HUE044428T2 (el)
LT (1) LT2723774T (el)
MX (1) MX337682B (el)
PL (1) PL2723774T3 (el)
PT (1) PT2723774T (el)
RS (1) RS59021B1 (el)
SI (1) SI2723774T1 (el)
TR (1) TR201909574T4 (el)
TW (1) TWI564010B (el)
WO (1) WO2012175608A1 (el)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6616725B2 (ja) * 2016-03-31 2019-12-04 日本製紙株式会社 塗工紙用澱粉
US20220062331A1 (en) 2019-01-10 2022-03-03 Pharmacosmos Holding A/S Treating iron deficiency in subjects at risk of cardiovascular adverse events and iron for the management of atrial fibrillation
CN114286682A (zh) 2019-02-09 2022-04-05 法码科思莫斯控股有限公司 治疗具有心血管不良事件风险的个体的铁缺乏以及用于治疗心房颤动的铁
AU2022323733A1 (en) 2021-08-03 2024-02-29 Pharmacosmos Holding A/S Iron complex compounds for subcutaneous use in therapy of iron deficiency in companion animals
CN117547549A (zh) * 2023-11-09 2024-02-13 黑龙江八一农垦大学 适用于犬arf的腹膜透析液与助清除剂的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3639588A (en) * 1966-10-22 1972-02-01 Fisons Pharmaceuticals Ltd Pharmaceutical compositions containing ferric hydroxide complexed with dextran or dextrin heptonic acids
US4370476A (en) * 1979-07-17 1983-01-25 Usher Thomas C Dextran polycarboxylic acids, ferric hydroxide complexes
GB8902894D0 (en) * 1989-02-09 1989-03-30 Fisons Plc Compositions
JPH0566372A (ja) * 1991-09-10 1993-03-19 Fukui Megane Kogyo Kk 金属製眼鏡フレーム部品の製造方法
JPH0776524A (ja) * 1993-07-13 1995-03-20 Takeda Chem Ind Ltd 動物用抗貧血剤
DK172860B1 (da) * 1998-03-25 1999-08-16 Pharmacosmos Holding As Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernman
JP3504506B2 (ja) 1998-09-17 2004-03-08 株式会社荏原製作所 消音装置
DK173138B1 (da) 1998-11-20 2000-02-07 Pharmacosmos Holding As Fremgangsmåde til fremstilling af en jerndextranforbindelse, jerndextranforbindelse fremstillet efter fremgangsmåden, farma
EP1762250A1 (en) 2005-09-12 2007-03-14 Fresenius Kabi Deutschland GmbH Conjugates of hydroxyalkyl starch and an active substance, prepared by chemical ligation via thiazolidine
CN101784514B (zh) * 2007-08-17 2013-12-04 阿克佐诺贝尔股份有限公司 谷氨酸n,n-二乙酰胺、谷氨酸n-乙酰胺n-乙腈、其碱金属盐、其制备方法及其用途
TWI469965B (zh) * 2008-12-22 2015-01-21 Ono Pharmaceutical Co 乙炔基吲哚化合物
JP5397991B2 (ja) * 2009-04-01 2014-01-22 学校法人東京農業大学 乳酸菌を用いたビタミンb12の定量方法

Also Published As

Publication number Publication date
EP2537866A1 (en) 2012-12-26
CN103649128A (zh) 2014-03-19
TWI564010B (zh) 2017-01-01
WO2012175608A1 (en) 2012-12-27
DK2723774T3 (da) 2019-07-15
LT2723774T (lt) 2019-08-12
SI2723774T1 (sl) 2019-08-30
PT2723774T (pt) 2019-07-15
PL2723774T3 (pl) 2019-10-31
EP2723774B1 (en) 2019-04-03
US20140128594A1 (en) 2014-05-08
CA2837784C (en) 2019-10-15
TR201909574T4 (tr) 2019-08-21
HK1220218A1 (zh) 2017-04-28
US9181353B2 (en) 2015-11-10
BR112013032901A2 (pt) 2017-01-24
CA2837784A1 (en) 2012-12-27
CN103649128B (zh) 2016-02-10
RS59021B1 (sr) 2019-08-30
US9631032B2 (en) 2017-04-25
MX2013015075A (es) 2014-04-14
MX337682B (es) 2016-03-15
JP2018100424A (ja) 2018-06-28
HUE044428T2 (hu) 2019-10-28
ES2733767T3 (es) 2019-12-02
HRP20191173T1 (hr) 2019-10-04
JP2014520188A (ja) 2014-08-21
TW201315474A (zh) 2013-04-16
US20160046733A1 (en) 2016-02-18
JP6370217B2 (ja) 2018-08-08
CN105348401A (zh) 2016-02-24
EP2723774A1 (en) 2014-04-30

Similar Documents

Publication Publication Date Title
CY1121976T1 (el) Μεθοδος για την παραγωγη παραγωγων υδροξυαιθυλαμυλου
CY1119605T1 (el) Παραγωγα 5-αρυλο ή 5-ετεροαρυλο υποκατεστημενου 3-υδροξυπυριδιν-2-υλ-καρβονυλαμινο-αλκανοϊκου οξεος και αλατα αυτων καθως και παρασκευη τους απο τα αντιστοιχα παραγωγα 3-υδροξυ-πικολινικου οξεος
CY1121695T1 (el) Ενωσεις και συνθεσεις ως αναστολεις κινασης c-kit
CY1121395T1 (el) Τετραϋδροπυριδοπυραζινες-διαμορφωτες toy gpr6
CY1125155T1 (el) Κρυσταλλικες μορφες αναστολεα προλυλο υδροξυλασης
CY1120029T1 (el) Παραγωγα 6-(5-υδροξυ-1η-πυραζολ-1-υλ) νικοτιναμιδιου και χρηση τους ως αναστολεις phd
BR112018070506A2 (pt) produção isenta de células de ácido ribonucleico
CY1115403T1 (el) Αλκυλαμινο-υποκατεστημενες δικυανοπυριδινες και προφαρμακα τυπου εστερα αμινοξεος αυτων
CY1120304T1 (el) Ενωσεις microrna και μεθοδοι για τη διαμορφωση της mir-21 δραστικοτητας
CY1115595T1 (el) Αλατα ρασιγιλινης και φαρμακευτικη παρασκευη αυτων
CY1121762T1 (el) Νεα μεθοδος κατεργασιας φυτικων προϊοντων πριν ή μετα τη συγκομιδη με το φωσφονικο οξυ και ενα αιθεριο ελαιο
UA114611C2 (uk) Пестицидні композиції і способи, що їх стосуються
CY1113985T1 (el) Μεθοδοι παραγωγης κυκλοαλκυλκαρβοξυαμιδο-πυριδινο βενζοϊκων οξεων
CL2008001897A1 (es) Proceso para la preparacion de 3-halometil-1-metil-1h-pirazol, utiles como intermediario en la produccion de fungicidas; compuestos derivados de 3-halometil-1-metil-1h-pirazol.
CY1121304T1 (el) Μεθοδος καθαρισμου σαπωνινων
UA111142C2 (uk) Одержання заміщених похідних 2-фторакрилової кислоти
BR112015032008A2 (pt) processamento de resíduo orgânico
CY1112520T1 (el) Βενζυλαμινες, μια διαδικασια για την παραγωγη τους και η χρηση τους ως αντι-φλεγμονωδεις παραγοντες
CR20110403A (es) Derivados de tiadiazoles y oxadiazoles, su preparación y su aplicación en terapia
CY1121859T1 (el) Μεθοδος παρασκευης αναστολεων συνθασης γλυκοζυλοκεραμιδης
CL2012000493A1 (es) Procedimiento de preparacion de 2-alquilamino-3-piridin-n-bencilpiperazin cetonas.
BR112016023811B8 (pt) Método para fabricação para derivados de triazina, pirimidina e piridina, seus intermediários e seus métodos de fabricação
FR2984322B1 (fr) Procede de fabrication de composes comprenant des fonctions nitriles
PH12016501704A1 (en) Method for producing 2-acyliminopyridine derivative
MX2012005733A (es) Metodo de produccion de derivados de acido glutamico marcados con f-18.